BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.0065
+0.0005 (8.33%)
Sep 21, 2026, 10:39 AM EST
BioRegenx Market Cap
BioRegenx has a market cap or net worth of $6.32 million as of September 23, 2026. Its market cap has decreased by -30.84% in one year.
Market Cap
6.32M
Enterprise Value
8.43M
Revenue
1.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
ChartMarket Cap Chart
Since March 12, 2024, BioRegenx's market cap has decreased from 49.89M to 6.32M, a decrease of -87.34%. That is a compound annual growth rate of -55.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 6.32M | -49.11% |
| Dec 31, 2025 | 12.41M | 44.15% |
| Dec 31, 2024 | 8.61M | -82.74% |
| Mar 12, 2024 | 49.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Healixa | 24.92M |
| CareView Communications | 20.49M |
| Pharma-Bio Serv | 10.08M |
| PreAxia Health Care Payment Systems | 9.47M |
| DATATRAK International | 8.93M |
| CompuMed | 8.58M |
| Vynleads | 7.51M |
| Resilient Healthcare | 3.31M |